Format

Send to

Choose Destination
Expert Rev Vaccines. 2003 Feb;2(1):113-27.

Pertussis: persistent pathogen, imperfect vaccines.

Author information

1
UCLA Center for Vaccine Research, Research and Education Institute at Harbor-UCLA Medical Center, Department of Pediatrics, Torrance, CA 90502, USA. syeh@rei.edu

Abstract

Routine use of pertussis vaccines has diminished the incidence of this disease but has not eliminated the pathogen. Pertussis remains a significant cause of disease in both very young infants and in the adolescent and adult populations. Acellular pertussis vaccines have fewer adverse reactions compared with whole-cell pertussis vaccines. Although efficacious against severe disease, current vaccines may not be as efficacious against milder forms of infection. New methodologies for understanding disease pathogenesis, immune responses and vaccine development are needed to effectively interrupt continued transmission of this pathogen.

PMID:
12901603
DOI:
10.1586/14760584.2.1.113
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center